Clinical Trials

36 enrolled

Phase 2 Not yet recruiting

Unresectable Non-small Cell Lung Cancer

NCT06747169 2024-12-27

Efficacy and Safety of Sintilimab Combined with Nab-PP Plus Rh-endostatin in Locally Advanced/advanced and Recurrent Metastatic Squamous Non-small Cell Lung Cancer: a Single-arm, Multicenter Clinical Study

32 enrolled

Squamous Non-Small Cell Lung Cancer SqNSCLC

NCT04267978 2024-10-15

Study of Recombinant Human Endostatin Combined with Temozolomide and Irinotecan in Recurrent Gliomas

109 enrolled

Glioblastoma, Recurrence

NCT05278715 2024-10-15

Modified CV Regimen in Optic Pathway Glioma

75 enrolled

Phase 2 Not yet recruiting

Optic Nerve Glioma

NCT06611826 2024-09-25

GEP Combined With Radiotherapy in Non-locally Treatable Recurrent NPC

41 enrolled

Nasopharyngeal Neoplasms

NCT06301828 2024-03-08

Endostar Combined With SBRT and Envafolimab in the Treatment of Advanced Gastrointestinal Tumors

16 enrolled

Gastrointestinal Neoplasms

NCT06279754 2024-02-28

Recombinant Human Endostatin Combined With Envafolimab and Synchronal Radiochemotherapy

Locally Advanced Squamous Non-small Cell Lung Cancer

NCT06047860 2023-09-21

A Clinical Study of Recombinant Human Vascular Endothelial Inhibitor in Combination With PRaG for Advanced Refractory Non-small Cell Lung Cancer

Tumor-Agnostic

Neoplasms

NCT02350517 2023-02-16

Endostar Combined With Paclitaxel and Nedaplatin in Treating Patients With Recurrent or Metastatic Esophageal Cancer

52 enrolled

Esophageal Squamous Cell Carcinoma

NCT05574998 2022-10-12

FTANLCNDG

100 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05551247 2022-09-22

Envafolimab Combined With Endostatin in Recurrent or Metastatic MSS-type Colorectal Cancer

Colorectal Neoplasms

NCT05529355 2022-09-07

Effect and Safety of Envafolimab Combined With Endostar/S-1 in Second-line of Advanced Non-small Cell Lung Cancer

45 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05514275 2022-08-24

Radiotherapy Combined With Endostatin and Capecitabine for NPC

41 enrolled

Nasopharyngeal Carcinoma

NCT05448781 2022-07-07

Recombinant Human Angioendostatin /PD-1 Mab Combined With First-line Chemotherapy in the Treatment of Driver Gene Negative Advanced NSCLC

38 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05360979 2022-05-04

A Clinical Study of Immunotherapy Combined With Chemotherapy and Anti-angiogenic Therapy in Operable NSCLC

42 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05298020 2022-03-28

Envafolimab Combined With Endostar and Chemotherapy for First-line Treatment of Advanced Pancreatic Cancer

20 enrolled

Advanced Pancreatic Cancer

NCT05243355 2022-02-17

Envafolimab Combined With Chemotherapy and Recombinant Human Endostatin in the First-line Treatment of Sq-NSCLC

46 enrolled

Squamous Non-small Cell Lung Cancer

NCT04942301 2021-06-30

PK Study for Endostar Continuous Intravenous Infusion in NSCLC Patients With 1st-line Platinum Based Chemotherapy

Phase 1 Unknown

24 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02636231 2021-02-03

Endostar for Locally Recurrent Nasopharyngeal Carcinoma

96 enrolled

Nasopharyngeal Carcinoma, Recurrence

NCT04613284 2020-11-03

RELIEF

Phase 4 Unknown

97 enrolled

Lung Neoplasms

NCT03989830 2020-10-23

SLICER

53 enrolled

Head and Neck Neoplasms

NCT04356118 2020-05-27

Efficacy and Safety of Recombinant Human Endostatin in Non-Small Cell Lung Cancer With Leptomeningeal Metastasis

Phase 4 Unknown

Meningeal Carcinomatosis

NCT03121833 2019-12-26

Endostar Combined With Chemotherapy for Stage Ⅳ Soft Tissue Sarcoma

52 enrolled

Sarcoma

NCT00004872 2019-12-13

Endostatin in Treating Patients With Advanced Refractory Solid Tumors

Phase 1 Completed

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT04121975 2019-10-10

CCRT Combined With Endostar for the Treatment of Locally Advanced Cervical Cancer

82 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT03932266 2019-04-30

Endostar Combined With Induction Chemotherapy and Concurrent Chemoradiotherapy for Locoregional Nasopharyngeal Carcinoma

73 enrolled

Nasopharyngeal Carcinoma

NCT03907098 2019-04-08

Endostar in Combination With Chemotherapy in HER-2 Negative Advanced Breast Cancer

50 enrolled

Breast

Breast Neoplasms

NCT02902432 2019-01-31

A Trial of Endostar in Patients With Carcinoma of the Head and Neck

24 enrolled

Nasopharyngeal Neoplasms

NCT02590133 2017-12-22

A Phase II Clinical Trial of Chemotherapy With or Without Endostar® Continuous Intravenous Infusion in Refractory NPC

328 enrolled

Nasopharyngeal Carcinoma

NCT01733589 2017-07-14

Recombinant Human Endostatin Continued Pumping Into Vein Combining With CCRT in Unresectable Stage III NSCLC

Phase 1/2 Completed

73 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03208335 2017-07-05

Recombinant Human Endostatin(Rh-endostatin) Combine With Radiotherapy in the Treatment of Hepatocellular Carcinoma(HCC)

61 enrolled

Carcinoma, Hepatocellular

NCT03123445 2017-04-21

Endostar First-line Treatment of Advanced NSCLC

150 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03117335 2017-04-17

Recombinant Endostatin Combined With Vinorelbine and Cisplatin in Patients With Advanced Non-small Cell Lung Cancer

Phase 3 Completed

560 enrolled

Carcinoma, Non-Small-Cell Lung

NCT01845675 2017-04-13

Chemotherapy Plus Endostatin in Advanced Pancreatic Neuroendocrine Tumor

14 enrolled

Adenoma, Islet Cell

NCT02104323 2017-02-09

Endostatin

20 enrolled

Neuroma, Acoustic, Neurofibromatosis 2

NCT03008109 2017-01-04

Endostar Plus EGFR-TKI（Epidermal Growth Factor Receptor-Tyrosine-Kinase Inhibitor） as a Treatment of EGFR Mutation-positive NSCLC

80 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02579564 2016-10-21

Systemic Chemotherapy Combined With Recombinant Human Adenovirus Type 5 and Endostatin Injections for Treatment Malignant Hydrothorax in NSCLC Patients

134 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02907710 2016-09-20

Endostar Combined With Concurrent Chemoradiotherapy for Locoregionally Advanced Nasopharyngeal Carcinoma

300 enrolled

Nasopharyngeal Carcinoma

NCT02804646 2016-06-21

Endostar Durative Transfusion Combined With Chemotherapy in the Treatment of Advanced Lung Adenocarcinoma

Phase 4 Unknown

100 enrolled

Adenocarcinoma of Lung

NCT02615106 2016-06-14

Anti-angiogenetic Therapy With Radiotherapy for Pediatric Neuroblastoma

60 enrolled

Neuroblastoma

NCT02745561 2016-04-20

Endostatin in Combination With Oxaliplatin and Radiotherapy in Esophageal Cancer Patients.

22 enrolled

Esophageal Neoplasms

NCT02630264 2015-12-15

E10A for the Treatment of Squamous Cell Carcinoma of the Head and Neck

540 enrolled

Head and Neck Neoplasms

NCT01430013 2015-11-04

Trial of Endostar Combined With CHOPT for T Cell Lymphoma

Lymphoid

Lymphoma, T-Cell

NCT02497118 2015-07-14

Recombinant Human Endostatin Combined With NP in Neoadjuvant Chemotherapy of Stage ⅢA NSCLC

Phase 4 Completed

Carcinoma, Non-Small-Cell Lung

NCT02375022 2015-03-24

Rh-Endostatin in Combination With Icotinib for Advanced NSCLC With EGFR Mutations

10 enrolled

Lung Neoplasms

NCT02350361 2015-01-29

Endostar Combination With Chemotherapy and EGFR-TKI in Lung Cancer Rechallenging Treatment After Acquired Resistance.

Phase 2/3 Unknown

60 enrolled

Lung Neoplasms

NCT01915134 2015-01-01

Endostatin in Combination With Chemotherapy for Metastatic Nasopharyngeal Carcinoma

362 enrolled

Nasopharyngeal Carcinoma

NCT01612286 2014-02-19

Endostar Combination With Chemotherapy for the Metastatic Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

NCT02005120 2013-12-20

Intrapleural Administration of Bevacizumab Versus Endostar for Pleural Effusions in NSCLC

20 enrolled